Great conversations and a packed room at the @UCBerkeley, last week!
We had the opportunity to hear from @JayBradner, EVP of R&D at @Amgen, on how scientific discovery translates into real-world medicine, followed by a thoughtful Q&A and networking with the biotech community.
Thanks to #MCBcDNA for hosting and to our co-sponsors, @genesismolai, @KopraBio, and UC Berkeley SCET, for helping bring the event together.
Always great to connect with researchers and teams pushing the boundaries of science forward.
#biotech #drugdiscovery #biopharma
We're excited to announce a new collaboration with Elephas to pair real-time tumor profiling with Mithrl’s AI Scientific Decision Engine (SDE). https://t.co/JIIT4pgyLP
By combining Elephas’ elive™ platform with Mithrl’s SDE, we’re establishing a foundation to integrate functional tumor profiling with AI-driven analysis, enabling more scalable and systematic discovery of novel immunotherapy response signals.
This scientific AI collaboration brings together:
- Real-time, ex vivo tumor profiling
- Multi-modal data integration
- Autonomous, multi-step scientific analysis under rigorous controls
Data from this work will be co-presented by @ Ada Shaw of Mithrl and @ Erika von Euw of Elephas as a joint poster at #AACR26:
• Multi-agent-augmented analysis of PD-1 checkpoint inhibitor response (#5695)
• April 20 | 9:00 AM – 12:00 PM PST
• Section 40
If you’ll be at #AACR26, stop by booth #5046 to connect with the Mithrl team and learn how agentic AI can support your research.
And a massive thank you to all of the incredible scientists and authors behind this work - we are so inspired by you!
The era of “using” #AIinscience is ending, and human–AI collaboration is here. IDT CTO Steven Henck shares insights from our #JPMWeek panel with @mithrl_ai about trust, data, and the rise of the hybrid scientist in the AI era. Read the full article: https://t.co/FJlaChPMiU
⏱️ 600 hours… now just a few days.
That’s what Prasun Agarwal, PhD, Bioinformatics Scientist at @NBISwe, experienced using Mithrl’s AI Co-Scientist for single-cell transcriptome analysis.
Thanks, Prasun, for sharing your feedback!
#SingleCell#Bioinformatics #SingleCellAnalysis #AIinBiology
We had a blast at @UCSF last week, discussing with researchers their work and the latest in agentic AI to accelerate discovery and delve deeper into transcriptomics, proteomics, and other research data.
It was great to share the tabletop space with fantastic companies and teams as well; what a welcoming community! @idtdna, @Elemental_io, @PackGeneBiotech, @MilliporeSigma, and more.
@GarredGarred #AIinLifeSciences #Proteomics #UCSF
@jermdemo@mithrl_ai@mithrl_ai is an ai assistant btw, more full-stack/platform than the ones listed above ( e.g., raw data to bio insights vis-à-vis a point solution!)
"Regulators don't fear AI. They fear black boxes." - Vivek Adarsh, Co-Founder & CEO, Mithrl
In our #JPM26 panel with healthcare and life sciences innovators, we explored the intersection of AI and biology. The panel considered how to uphold vital principles such as safety, transparency, and evidence-based science while harnessing AI's potential.
Hear a snippet of this discussion theme and connect with us to work together and set the standard for transparent AI technology in Life Sciences, for pharma, biotech, and beyond.
#JPM2026 @flyingthor
Attending #JPM26? Don’t miss this JPM Healthcare Satellite Event!
📅 Wed, Jan 14 | 5–8 PM
📍 100 Montgomery St, Ste. 1200, San Francisco
Register: https://t.co/iWfFN6KVXl
Join us for Happy Hour + Panel Discussions on AI & Biopharma Innovation, featuring industry leaders, expert insights, and gourmet food & drinks.
Speakers include:
✔️ Vivek Adarsh (@flyingthor), Co-Founder & CEO, @Mithrl
✔️ Mark Budde (@markwbudde), Co-Founder & CEO, @Plasmidsaurus
✔️ Rayyan Sheikh, Discovery & Innovation Research Leader, @Roche
✔️ Morten Sogaard, SVP Innovation, @AstellasUS
✔️ Steven Henck (@DNAbiotech), VP and NGS Fellow, Danaher (@idtdna)
✔️ Jimmy Lin, CSO, @freenome
✔️ Mia Nease, SVP Commercial, @dnanexus
✔️ Gordon Sanghera (@gordon_sanghera), Founder & CEO, @nanopore
✔️ Christopher Szeto (@ChrisSzetoPhD), Snr. Director of Discovery Bioinformatics, @ExelixisInc
✔️ Uli Stilz, Global BioPharma leader and Board Member
✔️ Hinco Gierman, CSO, Elephas
✔️ Jason T. Gammack (@Jason_Gammack), CEO, @AnsaBio
Moderated by John Cumbers (@johncumbers) (@SynBioBeta).
See you in SF!
#JPMHealthcareWeek
🚀 What are the value-based outcomes of AI in discovery science? Find out in the latest @mendelspod episode featuring our very own CEO and Co-Founder, Vivek Adarsh, PhD.
Theral Timpson sits down with Vivek to explore how Mithrl’s AI platform is turning weeks of bioinformatics analysis into minutes, helping researchers:
✔️ Identify new biomarker candidates in minutes instead of weeks
✔️ Catch costly errors before they happen
✔️ Multiply opportunities for “happy accidents” that can lead to discovery
Vivek also shares the vision behind Mithrl: building a true partner for science that accelerates the journey from raw data to real discovery.
🎧 Listen here: https://t.co/Gyo0F9wppn
@flyingthor #Mendelspod #AIinScience #Bioinformatics #Pharma
Excited to kick-off #BIOEurope- THE life sciences pharma partnering event of the year w/ 5,800+ attendees! Connect with Mithrl CEO, Vivek Adarsh @flyingthor to discuss how AI can transform pharma R&D, driving higher discovery program ROI & new patent opportunities for R&D teams.
Ever wondered what it's like to have a co-scientist who doesn't steal your coffee or mislabel your samples? That’s what we’ll be talking about in this exciting panel next week.
Ahead of their panel at #SynBioBeta2025 in San Jose, @flyingthor, co-founder of @mithrl_ai, discussed how AI-driven agents are transforming scientific research.
read full article: https://t.co/Aa2Ln8xEY1
Great to see @mithrl_ai featured in this @CNBC piece about AI startups redefining the San Francisco's office culture.
At Mithrl, in-person collaboration is more than just a preference—it’s core to our mission and culture. We believe that the best ideas and breakthroughs happen when brilliant minds share the same space, whether it’s during brainstorming sessions, over coffee, or in the heat of some healthy competition at our ping-pong table. 🏓 (The leaderboard is fierce, but we’re always looking for challengers!)
A wave of San Francisco early stage startups are going back in office 4+ days a week, and they're competing for deals on office spaces in the city that they couldn't have landed pre-pandemic
My latest for CNBC: https://t.co/A4kYYNYoeC
Excited to lead @mithrl_ai $4M Seed round! 🧬
Their AI platform turns months of biotech data analysis into minutes. Scientists building for scientists. The future of breakthrough discoveries just got faster! 🚀
Congrats @mithrl_ai
https://t.co/HaBbWWNnvo
I'm thrilled to announce @mithrl_ai's oversubscribed $4 Million round, led by @bonfire_vc 🔥 with participation from our previous investors and biotech industry insiders! Thanks @axios for covering this. This achievement is a testament to our exceptionally talented team and the incredible customers who partner with us every day.
For all of us, this isn’t just a milestone—it’s an opportunity to push forward in our mission to accelerate scientific breakthroughs. We’ve all seen the toll that illness and slow scientific progress can take on people’s lives. Knowing that science often takes longer than we can afford, we set out to change this. Time saved in scientific research doesn’t just lead to faster results; it leads to real lives saved. Mithrl became our answer to this challenge, driven by our shared belief that scientific progress shouldn’t wait.
https://t.co/7CvSErdSuY